Tumor Suppressing Properties of Rodent Parvovirus NS1 Proteins and Their Derivatives
- 16 June 2014
- book chapter
- Published by Springer Nature
- Vol. 818, 99-124
Abstract
Cancer chemotherapy with monospecific agents is often hampered by the rapid development of tumor resistance to the drug used. Therefore, combination treatments aiming at several different targets are sought. Viral regulatory proteins, modified or not, appear ideal for this purpose because of their multimodal killing action against neoplastically transformed cells. The large nonstructural protein NS1of rodent parvoviruses is an excellent candidate for an anticancer agent, shown to interfere specifically with cancer cell growth and survival. The present review describes the structure, functions, and regulation of the multifunctional protein NS1, its specific interference with cell processes and cell protein activities, and what is known so far about the mechanisms underlying NS1 interference with cancer growth. It further outlines prospects for the development of new, multimodal cancer toxins and their potential applications.Keywords
This publication has 101 references indexed in Scilit:
- Synergistic combination of valproic acid and oncolytic parvovirus H‐1PV as a potential therapy against cervical and pancreatic carcinomasEMBO Molecular Medicine, 2013
- Recruitment of DNA replication and damage response proteins to viral replication centers during infection with NS2 mutants of Minute Virus of Mice (MVM)Virology, 2011
- Enhancement of NK cell antitumor responses using an oncolytic parvovirusInternational Journal of Cancer, 2010
- Regression of advanced rat and human gliomas by local or systemic treatment with oncolytic parvovirus H-1 in rat modelsNeuro-Oncology, 2010
- AKT-Independent Signaling Downstream of Oncogenic PIK3CA Mutations in Human CancerCancer Cell, 2009
- Arming parvoviruses with CpG motifs to improve their oncosuppressive capacityInternational Journal of Cancer, 2008
- Parvovirus interference with intracellular signalling: mechanism of PKCη activation in MVM-infected A9 fibroblastsCellular Microbiology, 2008
- A viral adaptor protein modulating casein kinase II activity induces cytopathic effects in permissive cellsProceedings of the National Academy of Sciences, 2007
- Parvovirus H-1-Induced Tumor Cell Death Enhances Human Immune Response In Vitro via Increased Phagocytosis, Maturation, and Cross-Presentation by Dendritic CellsHuman Gene Therapy, 2005
- Antineoplasic activity of parvovirusesJournal of Virological Methods, 1991